Enrolling By InvitationNCT05170919
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
Medication studyAges 18+United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- EnglewoodSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 20, 2022
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 170
- Sponsor
- Englewood Hospital and Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05170919
- Official title
Show the full official title
An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Englewood
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Englewood Hospital and Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Mirtazapine and Olanzapine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
